COMMUNIQUÉS West-GlobeNewswire

Novan Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/06/2018 - 14:05

MORRISVILLE, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today reported that the Compensation Committee of Novan’s Board of Directors granted stock options to purchase an [...]

Genocea to Present at Jefferies 2018 Global Healthcare Conference

01/06/2018 - 14:04

Presentation to be webcast live at 12:30 pm ET on June 8, 2018 CAMBRIDGE, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer [...]

Novartis completes sale of stake in consumer healthcare joint venture to GSK for USD13.0 billion

01/06/2018 - 14:01

Basel, June 1, 2018 - Novartis AG ("Novartis") today announced the completion of the divestment to GlaxoSmithKline PLC ("GSK") of its 36.5 percent stake in a consumer healthcare joint venture (JV) for a total [...]

Rhythm Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference

01/06/2018 - 14:00

BOSTON, June 01, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity [...]

Kane Biotech to Showcase Technologies and Products at the 2018 BIO International Convention

01/06/2018 - 14:00

WINNIPEG, Manitoba, June 01, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that it will be attending the 2018 BIO International [...]

Spero Therapeutics to Present at the Jefferies 2018 Healthcare Conference in June

01/06/2018 - 14:00

CAMBRIDGE, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]

Cynata’s Cymerus™ MSCs Effective in Preclinical Model of Diabetic Wounds

01/06/2018 - 14:00

MELBOURNE, Australia, June 01, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce that it has received positive data [...]

resTORbio to Present at the Jefferies 2018 Global Healthcare Conference

01/06/2018 - 14:00

BOSTON, June 01, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]

BioDelivery Sciences to Present at the William Blair 2018 Growth Stock Conference

01/06/2018 - 14:00

RALEIGH, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading specialty pharmaceutical company in the field of pain management and addiction medicine, announced [...]

Immunomedics Announces Pivotal Study of Sacituzumab Govitecan in Patients With Locally Advanced or Metastatic Urothelial Cancer

01/06/2018 - 14:00

MORRIS PLAINS, N.J., June 01, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]

Immune Design to Host June 4 Cancer Immunotherapy Event in Chicago and Present at Jefferies 2018 Global Healthcare Conference in New York

01/06/2018 - 14:00

SEATTLE and SOUTH SAN FRANCISCO, Calif., June 01, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), an immunotherapy company focused on novel therapies in oncology, today announced that the company will host an [...]

Key CareDx Events Scheduled at American Transplant Congress 2018

01/06/2018 - 14:00

CareDx will have a strong presence at ATC, all major US transplant centers will be in attendance BRISBANE, Calif., June 01, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on [...]

CLS Holdings USA Comments on Application Process for Additional Nevada Dispensaries

01/06/2018 - 14:00

LAS VEGAS, June 01, 2018 (GLOBE NEWSWIRE) -- (OTCQB:CLSH) CLS Holdings USA, Inc. “CLS,” a development stage diversified Cannabis Company operating as Cannabis Life Sciences, today announced Oasis Cannabis plans to apply [...]

Oryzon to present at upcoming international conferences

01/06/2018 - 14:00

BIO International Convention 2018, Boston, Ma, USA Jefferies 2018 Global Healthcare Conference, New York, USA 14 th Spring European Midcap Event, Paris, France MADRID, Spain and CAMBRIDGE, Mass., June 01, 2018 (GLOBE [...]

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

01/06/2018 - 14:00

Expanding global oncology testing for clinical trials WILMINGTON, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- Pharmaceutical Product Development, LLC ( PPD ), a leading global contract research organization (CRO), and [...]

MYALEPTA® (metreleptin) Receives Positive CHMP Opinion in Patients with Generalized and Partial Lipodystrophy

01/06/2018 - 13:54

Europe represents potentially the largest market for metreleptin with expected authorization in both generalized and partial lipodystrophy VANCOUVER, British Columbia, June 01, 2018 (GLOBE NEWSWIRE) -- Novelion [...]

Sandoz receives positive CHMP opinion for proposed biosimilar adalimumab

01/06/2018 - 13:45

Sandoz is seeking approval of proposed biosimilar adalimumab for use in all reference medicine indications including those in rheumatology, gastroenterology and dermatology Positive CHMP opinion based on comprehensive [...]

Novartis receives positive CHMP opinion for Aimovig® (erenumab) for the prevention of migraine

01/06/2018 - 13:41

If approved, Aimovig ® (erenumab) is expected to be the first and only available therapy designed specifically for migraine prevention in the EU Positive opinion based on robust data package demonstrating Aimovig's [...]

Oncolytics Biotech® Announces Listing on Nasdaq Capital Market

01/06/2018 - 13:40

CALGARY, Alberta and SAN DIEGO, June 01, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (NASDAQ:ONCY), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]